At this time, posts about Genexine are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 15,000 shares today. Genexine is known as a company specializing in the development of biopharmaceuticals.


As of 12:30 PM on the 14th, Genexine's stock price is 132,600 KRW, up 0.84% from the previous day, with a trading volume of 1,148,501 shares, which is 75.73% of the 5-day average trading volume.


In addition to Genexine, posts by investors are also rapidly increasing for Jangwon Tech (174880), Sambu Construction (001470), and ST Pharm (237690).



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing